AJP - Heart Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 286: H1608-H1614, 2004. First published January 2, 2004; doi:10.1152/ajpheart.01056.2003
0363-6135/04 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
286/5/H1608    most recent
01056.2003v2
01056.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wood, K. C.
Right arrow Articles by Granger, D. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wood, K. C.
Right arrow Articles by Granger, D. N.

Endothelial cell P-selectin mediates a proinflammatory and prothrombogenic phenotype in cerebral venules of sickle cell transgenic mice

Katherine C. Wood,1 Robert P. Hebbel,2 and D. Neil Granger1

1Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130; and 2Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota 55455

Submitted 5 November 2003 ; accepted in final form 22 December 2003


   ABSTRACT
TOP
 ABSTRACT
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Whereas the adhesion of leukocytes and erythrocytes to vascular endothelium has been implicated in the vasooclusive events associated with sickle cell disease, the role of platelet-vessel wall interactions in this process remains undefined. The objectives of this study were to: 1) determine whether the adhesion of platelets and leukocytes in cerebral venules differs between sickle cell transgenic ({beta}S) mice and their wild-type (WT) counterparts (C57Bl/6) under both resting and posthypoxic conditions, and 2) define the contributions of P-selectin to these adhesion processes. Animals were anesthetized, and platelet and leukocyte interactions with endothelial cells of cerebral postcapillary venules were monitored and quantified using intravital fluorescence microscopy in WT, {beta}S, and chimeric mice produced by transplanting bone marrow from WT or {beta}S mice into WT or P-selectin-deficient (P-sel–/–) mice. Platelet and leukocyte adhesion to endothelial cells in both unstimulated and posthypoxic {beta}S mice were significantly elevated over WT levels. Chimeric mice involving bone marrow transfer from {beta}S mice to P-sel–/– mice exhibited a profound attenuation of both platelet and leukocyte adhesion compared with {beta}S bone marrow transfer to WT mice. These findings indicate that {beta}S mice assume both an inflammatory and prothrombogenic phenotype, with endothelial cell P-selectin playing a major role in mediating these microvascular responses.

platelet; leukocyte; brain; bone marrow transplant

SICKLE CELL DISEASE (SCD) is a painful and life-threatening condition that involves multiple organ pathology, including acute chest syndrome and stroke. Studies on the pathogenesis of SCD have revealed that the vasculature is a principal target of the disease (3, 14) and that the affected tissues assume an inflammatory phenotype (7, 12, 21). Enhanced cytokine production (8, 23), oxidative stress (18, 26, 28), altered endothelium-dependent vasorelaxation (19), and increased endothelial cell adhesion molecule expression (9, 32, 33) are manifestations of the inflammatory state that occurs during SCD. Recent studies using the sickle transgenic mouse model have revealed increased adhesive interactions between circulating erythrocytes and leukocytes with the walls of postcapillary venules, which may impede microvascular perfusion and promote vasoocclusive crises. These adhesion responses appear to involve both direct adhesive interactions of the circulating blood cells with venular endothelium and indirect interactions that involve the binding of erythrocytes to leukocytes already adherent to venular endothelium (40). A role for P-selectin in mediating leukocyte and erythrocyte interactions in mice with SCD has been demonstrated using both blocking monoclonal antibodies (18) and P-selectin knockout mice (40).

There is a growing body of evidence that implicates platelets in the vasculopathy of both small and large blood vessels observed in SCD. Platelets from SCD patients exhibit an abnormal phenotype marked by surface-mobilized, activation-dependent antigens and microparticle morphology (37, 46). Increased circulating levels of platelet products (thrombospondin, IL-1) have been noted in SCD patients and have been implicated in the abnormal adhesion of SCD erythrocytes (2, 4, 34). It has been demonstrated that antibodies directed against the thrombospondin receptor (reticulocyte CD36) dramatically inhibit platelet supernatant-mediated adhesion of SCD erythrocytes to monolayers of cultured endothelial cells (4, 34). Furthermore, studies of large vessel cerebral arterial disease in SCD stroke patients have revealed hyperplastic arterial vessels with overlying thrombi (10). Despite evidence that SCD patients are more prone to thrombus formation (16, 25, 43, 45) and its consequences (e.g., stroke), there has been no reported effort to determine whether circulating SCD platelets, like erythrocytes and leukocytes, exhibit enhanced adhesive interactions within the microvasculature. This possibility appears tenable inasmuch as P-selectin, which mediates the adhesion of erythrocytes and leukocytes in venules of SCD mice (18, 40), has been implicated in the recruitment of adherent platelets in murine venules exposed to inflammatory conditions such as ischemia-reperfusion (24) and hypercholesterolemia (36). Most intravital microscopic studies of the microvascular responses to SCD have focused on skeletal muscle circulation (cremaster) despite limited evidence implicating muscle involvement in this disease. The organ systems most profoundly affected by SCD include the lung, brain, kidney, spleen, and long bones. An important clinical consequence of the cerebral vascular response to SCD is stroke. Brain involvement in SCD is not uncommon, especially in children. Indeed, the prevalence of stroke in the SCD population is reported to range between 6 and 30% (20, 30, 31). Although the cerebral circulation is known to be a major target organ in the pathologenesis of SCD, there has been no documented attempt to examine the brain microvascular responses to SCD. In this study, the cerebral microcirculation was examined in wild-type (WT) and sickle cell transgenic ({beta}S) mice to 1) determine whether SCD is associated with platelet and/or leukocyte adhesion in cerebral postcapillary venules under both unstimulated conditions and following hypoxia-reoxygenation (H/R), 2) define the contribution of P-selectin to the adhesion of platelets and leukocytes in the cerebral microcirculation of {beta}S mice, and 3) determine the relative contributions of endothelial cells versus platelets in mediating the prothrombogenic phenotype that develops in cerebral venules during SCD.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Animals. WT C57BL/6 mice, CD45 congenic B6.SJL-PTPRCPEP/BOY mice (which express CD45.1), and B6.129S7-sELPTMLBAY (P-selectin–/–) mice on a C57BL/6 background were obtained from Jackson Laboratories (Bar Harbor, ME). {beta}S mice and their negative controls (C57Bl/6) were provided by Dr. Robert P. Hebbel, Dept. of Medicine, University of Minnesota. The {beta}S mice, developed on a mixed genetic background (FVB/N, 129, DBA/2, C57BL/6, and Black Swiss) (29), are homozygous for knockout of murine {alpha}-globin and heterozygous for knockout of murine {beta}-globin and have one copy of the linked transgenes for human {alpha}- and human {beta}S-globins. The animals were 6–8 mo old and housed under specific pathogen-free conditions. The mice were maintained on standard laboratory chow and fed ad libitum until immediately before the experiments.

Chimeras. Four combinations of bone marrow chimeras were produced. WT/WT chimeras were WT animals (CD45.2-positive leukocytes) that received bone marrow cells from CD45 congenic mice (CD45.1-positive leukocytes). This resulted in a significant increase of leukocytes expressing CD45.1 (of donor origin) from <5% in WT to >90% in the WT/WT chimeras, allowing verification of proper chimera reconstitution, as previously described (38). {beta}S/WT chimeras were produced by transplanting bone marrow from {beta}S mice (CD45.1-positive leukocytes) into WT mice (CD45.2-positive leukocytes). WT/{beta}S chimeras were produced by transplanting bone marrow from WT mice (CD45.2-positive leukocytes) into {beta}S mice (CD 45.1-positive leukocytes). Previous studies have shown that {beta}S/WT chimeras assume the sickle phenotype a few weeks after transplantation of the {beta}S marrow (40). Likewise, WT/{beta}S chimeras assumed a normal (WT) phenotype a few weeks after transplantation of WT marrow into {beta}S mice. In some experiments, {beta}S bone marrow (CD 45.1-positive leukocytes) was transferred into P-selectin–/– mice (CD45.2-positive leukocytes) yielding {beta}S/P-selectin–/– chimeras with intact P-selectin on {beta}S blood cells and a P-selectin deficient vessel wall.

Bone marrow cells were isolated from the femurs and tibias of donor mice and resuspended at 4 x 107 cells/ml phosphate-buffered saline (PBS). Recipient mice were irradiated with two doses of 500–525 rad, 3 h apart, after which 8 x 106 donor bone marrow cells in 200 µl of PBS were administered via the femoral vein. The chimeras were kept in autoclaved cages, with 0.2% neomycin sulfate (Sigma) in the drinking water for 2 wk, after which normal drinking water was used. Seven weeks after reconstitution, only chimeric mice demonstrating 90% or better conversion of leukocyte antigen to donor phenotype were subjected to 2 h hypoxia, followed by 4 h reoxygenation, and prepared for intravital microscopy using the closed cranial window preparation. Flow cytometry was used to verify chimera reconstitution in all animals by staining for CD45.1 expression on leukocytes with a FITC-labeled anti-CD45.1 antibody (PharMingen).

Surgical protocol. All animals were anesthetized intraperitoneally with ketamine hydrochloride (50 mg/kg) and pentobarbitol (50 mg/kg). The left femoral artery was cannulated for monitoring mean arterial blood pressure (BP-1, World Precision Instruments) and sampling arterial blood for blood gas analysis (Omni-Modular System), whereas the femoral vein was cannulated for intravenous administration of carboxyfluorescein succinimidyl ester (CFSE, Molecular Probes; Eugene, OR)-labeled platelets and/or acridine orange (Sigma; St. Louis, MO) for in vivo labeling of leukocytes. Core body temperature was maintained at 35 ± 0.5°C. The experimental procedures described above were reviewed and approved by the Louisiana State University Health Sciences Center-Shreveport Institutional Animal Care and Use Committee and performed according to the criteria outlined in the National Institutes of Health guidelines.

Experimental preparation. Both male and female mice were studied. Mice were maintained on normal mouse chow until 6 h before the experiment. Mice subjected to hypoxia-reoxygenation were placed individually in a hypoxia chamber (10% O2-0.05% CO2, balance nitrogen) for 2 h and then returned to normoxic conditions for 1.5 h before the induction of anesthesia. Mice used for baseline (unstimulated) experiments were handled identically but the hypoxic insult was omitted. Lidocaine (1%) was used for local anesthesia. All mice were tracheostomized and mechanically ventilated (Harvard Rodent Ventilator model 683; South Natick, MA) with room air. The head of each mouse was fixed in a stereotaxic frame, and the left parietal bone was exposed by a longitudinal midline skin incision. Two polyethylene-50 tubes (Clay Adams; Parsippany, NJ) were fixed on the skull with ethyl cyanoacrylate (Elmer's Products; Columbus, OH), and a closed cranial window was constructed. A craniectomy was made by using a high-speed microdrill (Fine Science Tools; Foster City, CA), the dura was carefully reflected, and a cover glass, affixed with a quick self-curing acrylic resin (Biobond, Japan), was used to render the window air-tight. Artificial cerebrospinal fluid (Na+ 147.8 meq/l, K+ 3.0 meq/l, Mg2+ 2.3 meq/l, Ca2+ 2.3 meq/l, Cl– 135.2 meq/l, HCO–3 19.61 meq/l, lactate 1.67 meq/l, phosphate 1.1 mmol/l, and glucose 3.9 mmol/l) filled the space beneath the cranial window. The animals were allowed to stabilize for 30 min before observation of postcapillary venules under an upright Nikon Xanophot microscope (HLX64610. Venular branches of the anterior, superior, and middle cerebral arteries were scanned, and images of 1-min duration were videotaped using a videocassette recorder (BR-S601MU, JVC; Japan) for each of 5 nonoverlapping 300-µm venular segments (20–80 µm diameter). A time-date recorder (WJ810, Panasonic) displayed a stopwatch function onto the video screen.

Circulating cell-endothelial cell interactions. Monitoring the activity of circulating cells with each other and the endothelium in the cerebral microcirculation required fluorescent labeling of cells: leukocytes were labeled in vivo with acridine orange (0.05% in 100 µl), and platelets were labeled ex vivo with CFSE (90 µM). The following manipulations, which have been shown to have no significant effect on the activity or viability of isolated platelets as assessed by flow cytometry (36), were used to isolate and label donor platelets from WT and {beta}S mice. Platelets were isolated from whole blood obtained via the carotid artery of donor mice. The blood was collected in a polypropylene tube containing 0.1 ml acid citrate dextrose (Sigma) buffer and then centrifuged twice at 120 g for 8 and 3 min. Between centrifugations, platelet-rich plasma (PRP) was removed by pipette and placed in a clean polypropylene tube. The PRP was centrifuged at 550 g for 10 min to pellet the platelets. The platelet pellet was gently resuspended in 1,500 µl PBS (pH 7.4) and incubated with the fluorescent dye CFSE for 10 min at room temperature. The platelets were then centrifuged for 10 min at 550 g, resuspended in 500 µl PBS, and protected from light until use. Contamination of the platelet suspension by leukocytes was evaluated from a 25-µl sample and did not exceed 0.01%. Leukocytes were stained by the addition of 465 µl 3% citric acid and 10 µl 1% crystal violet (Sigma) and quantified with the aid of a hemocytometer and light microscope. Platelets (100 x 106) were infused over 5 min, yielding ~5% of the total platelet count. Infused platelets were allowed to circulate for a period of 5 min before being videotaped.

Estimates of pseudoshear rate in venules were obtained using measurements of venular diameter (Dv) and the maximal velocity of flowing platelets (Vplt) according to the formulation: pseudoshear rate = (Vplt/1.6)/Dv x 8 (39).

Intravital fluorescence microscopy. Platelets were visualized, as previously described (6), with a Nikon Xanophot upright microscope assisted by a silicon intensified target camera (C-2400, Hamamatsu Photonics). Cerebral venules were epi-illuminated, observed through a 20x long distance objective lens (Leitz Weitzler), and recorded on videotape using a videocassette recorder (BRS601MU, JVC). A video time/date generator projected the time, date, and stopwatch function on the monitor (diagonal 50.6 cm, PVM-2030, Sony Trinitron). CFSE (excitation: 490 nm, emission: 518 nm) and acridine orange (excitation: 500 nm, emission: 526 nm) visualization required a filter block with an excitation filter (B-2A, Nikon) for 450–490 nm, a dichroic mirror for 510 nm, and a barrier filter of 520 nm. The cerebral surface was scanned for five nonoverlapping venular segments per animal, and each was recorded for 1 min. Platelet and leukocyte adhesion were quantified separately within cerebral venules.

Video analysis. Leukocyte and platelet interactions with the endothelium were determined by offline analysis of videotaped images as previously described (5). Nonoverlapping venular segments of 300 µm length with diameters ranging between 20 and 80 µm (51.1 mean diameter) were chosen for quantification of adherent cells. Platelets and leukocytes were considered adherent if they arrested on the vascular endothelium >=2 s. Platelet adherence was expressed as the number of cells per square millimeter of venular surface, calculated from diameter and length, assuming cylindrical vessel shape (24).

Statistical analysis. All values are reported as means ± SE. ANOVA with the Fisher's post hoc test was used to compare groups, with statistical significance set at P < 0.05.


   RESULTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Comparisons of arterial blood pressure (79.8 ± 3.1 vs. 76.9 ± 3.1 mmHg), venular diameter (52.2 ± 2.7 vs. 53.1 ± 2.6 µm), and venular pseudoshear rate (400.4 ± 40.5 vs. 305.4 ± 29.7 s–1) between unstimulated WT and {beta}S mice revealed no statistically significant differences. Figure 1 illustrates that the number of adherent leukocytes in the cerebral venules of unstimulated {beta}S mice (60 ± 11 cells/mm2) was approximately twice the adhesion detected in their unstimulated WT counterparts (34 ± 5 cells/mm2, P = 0.047). This finding is consistent with previous reports of a twofold increase in leukocyte adhesion in cremasteric postcapillary venules of {beta}S mice.



View larger version (13K):
[in this window]
[in a new window]
  		Fig. 1. Leukocytes adhere in cerebral postcapillary venules of unstimulated sickle cell transgenic ({beta}S) mice. Mean responses of in vivo fluorescently labeled leukocytes adherent for >=2 s in wild-type (WT) and {beta}S mice. Seven to 16 animals were studied in each group. *Significant differences, P < 0.05 (one-way ANOVA and Fisher's test).

 

Major objectives of this study were to determine whether larger numbers of adherent platelets are observed in cerebral venules of {beta}S mice (compared with WT) and to define the contribution of platelets versus endothelial cells to any platelet-vessel wall interactions that are elicited in venules of {beta}S mice. When platelets isolated from {beta}S donors were monitored in venules of {beta}S recipients ({beta}S -> {beta}S), significant platelet adhesion (654 ± 240 cells/mm2) was noted, and the intensity of adhesion was significantly higher than that observed when WT platelets were monitored in WT recipients (WT -> WT; 147 ± 35 cells/mm2, P = 0.03) (Fig. 2). When platelets isolated from WT donors were infused into {beta}S recipients (WT -> {beta}S), platelet adhesion (454 ± 141 cells/mm2) was similar to that noted in {beta}S controls ({beta}S -> {beta}S). However, when platelets isolated from {beta}S donors were infused into WT recipients ({beta}S -> WT), platelet adhesion (101 ± 50 cells/mm2) was similar to that noted in WT controls (WT -> WT; 147 ± 35 cells/mm2), i.e., minimal platelet adhesion was observed. These experiments revealed that platelet adhesion in unstimulated {beta}S mice is significantly increased compared with WT mice, and this thrombogenic response is endothelial cell dependent.



View larger version (30K):
[in this window]
[in a new window]
  		Fig. 2. Platelets adhere in cerebral postcapillary venules of unstimulated {beta}S mice. Ex vivo fluorescently labeled donor WT or {beta}S platelets were infused into WT or {beta}S recipients to yield the following four groups: WT platelets infused into WT recipients (WT -> WT), {beta}S platelets infused into {beta}S recipients ({beta}S -> {beta}S), WT platelets infused into {beta}S recipients (WT -> {beta}S), and {beta}S platelets infused into WT recipients ({beta}S -> WT). Mean responses of platelets adherent for >=2 s. Five to 8 animals were studied in each group. *Significant difference versus WT -> WT; #significant difference versus {beta}S -> {beta}S, P < 0.05 (one-way ANOVA and Fisher's test).

 

Another objective of the study was to determine whether 2 h of whole body hypoxia (10% O2-0.05% CO2, balance nitrogen) followed by 4 h reoxygenation (room air) alters the adhesion of leukocytes and platelets in the cerebral venules of {beta}S and WT mice (Figs. 3 and 4). WT mice challenged with H/R exhibited leukocyte (27 ± 6 vs. 34 ± 5 cells/mm2) and platelet (124 ± 44 vs. 147 ± 35 cells/mm2) adhesion responses that are similar to those seen in normoxic WT mice. The response of leukocyte adhesion to H/R in controls is consistent with published reports that address H/R-induced responses in cremasteric venules of SCD mice. When {beta}S mice were exposed to H/R, platelet adhesion was unaffected compared with their normoxic, unstimulated counterparts (571 ± 171 vs. 654 ± 240 cells/mm2). Although leukocyte adhesion was enhanced by H/R in {beta}S mice, this response was not statistically significant (86 ± 18 vs. 59 ± 10 cells/mm2).



View larger version (13K):
[in this window]
[in a new window]
  		Fig. 3. Hypoxia-reoxygenation (H/R)-induced leukocyte adhesion in {beta}S mice. Effects of H/R on leukocyte adhesion in cerebral postcapillary venules of WT and {beta}S mice are shown. Mean responses of leukocytes adherent for >=2 s. 15 to 16 animals were studied in each group. *Significant differences, P < 0.05 (one-way ANOVA and Fisher's test).

 


View larger version (13K):
[in this window]
[in a new window]
  		Fig. 4. H/R-stimulated platelet adhesion is similar to baseline adhesion in {beta}S mice. The effects of H/R on platelet adhesion in cerebral postcapillary venules of WT and {beta}S mice are shown. Mean responses of platelets adherent for >=2 s. Six to 8 animals were studied in each group. *Significant differences, P < 0.05 (one-way ANOVA and Fisher's test).

 

The role of endothelial cell P-selectin in mediating the leukocyte and platelet adhesion responses to H/R in {beta}S mice was addressed in the bone marrow of chimeric mice (Figs. 5 and 6). Transfer of marrow from {beta}S mice into WT mice ({beta}S/WT) yielded significantly higher H/R-induced leukocyte (67 ± 12 vs. 24 ± 10 cells/mm2, P = 0.01) and platelet (914 ± 198 vs. 175 ± 79 cells/mm2, P = 0.002) adhesion responses compared with WT mice receiving bone marrow from WT mice (WT/WT). However, the transfer of bone marrow from {beta}S mice into P-selectin–/– mice ({beta}S/P-sel–/–) yielded leukocyte (30 ± 7 vs. 24 ± 10 cells/mm2) and platelet (284 ± 53 vs. 175 ± 79 cells/mm2) adhesion responses to H/R that were no different from those noted in WT/WT chimeras and were significantly reduced compared with leukocyte (67 ± 12 cells/mm2, P = 0.03) and platelet (914 ± 198 cells/mm2, P = 0.004) adhesion responses observed in {beta}S/WT chimeras. These observations are consistent with the transfer of both the inflammatory and prothrombogenic phenotypes into WT mice following transplantation of bone marrow derived from {beta}S mice. In addition, the blunted adhesion responses of platelets and leukocytes in {beta}S/P-selectin–/– chimeric mice strongly implicates endothelial cell-associated P-selectin in these adhesion responses.



View larger version (22K):
[in this window]
[in a new window]
  		Fig. 5. Endothelial cell-associated P-selectin mediates H/R-stimulated leukocyte adhesion in {beta}S chimeras. Effects of H/R (2 h hypoxia, 4 h reoxygenation) on leukocyte-endothelial (L/E) adhesion in cerebral postcapillary venules of WT control chimeras (WT/WT), {beta}S chimeras ({beta}S/WT), and {beta}S/P-selectin–/– chimeras ({beta}S/P-selectin–/–) are shown. Mean responses of leukocytes adherent for >=2 s. Five to 7 animals were studied in each group. #Significant difference versus WT/WT; *significant difference versus {beta}S/WT, P < 0.05 (one-way ANOVA and Fisher's test).

 


View larger version (22K):
[in this window]
[in a new window]
  		Fig. 6. Endothelial cell-associated P-selectin mediates H/R-stimulated platelet adhesion in {beta}S chimeras. Effects of H/R (2 h hypoxia, 4 h reoxygenation) on platelet-endothelial cell (P/E) adhesion in postcapillary cerebral venules of WT control chimeras (WT/WT), {beta}S chimeras ({beta}S/WT), and {beta}SP-selectin–/– chimeras ({beta}S/P-selectin–/–) are shown. Mean responses of WT platelets adherent for >=2 s. Five animals were studied in each group. *Significant difference versus WT/WT; #significant difference versus {beta}S/WT, P < 0.05 (one-way ANOVA and Fisher's test).

 


   DISCUSSION
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
There is a growing body of evidence indicating that acute and chronic inflammatory conditions are associated with microvascular dysfunction, which is characterized by endothelial cells that assume both an inflammatory and prothrombogenic phenotype. For example, the recruitment of rolling and adherent leukocytes in postcapillary venules exposed to ischemia and reperfusion is accompanied by an intense accumulation of rolling and firmly adherent platelets (24). Colocalization of adherent platelets and leukocytes has been observed in response to transient retinal ischemia (17, 27, 39), as well as in venules of experimental animals with chronic arterial hypertension (1, 13, 22, 35). The results of the present study indicate that sickle cell disease is another pathological condition that produces both an inflammatory and prothrombogenic state in the microcirculation.

The results of our study demonstrate that SCD affects the cerebral microcirculation by 1) promoting the adhesion of platelets and leukocytes to venular endothelium, 2) inducing platelet and leukocyte adhesion responses that are P-selectin dependent, and 3) eliciting platelet and leukocyte responses that result primarily from changes in the function/adhesivity of endothelial cells, rather than circulating blood cells. The endothelial P-selectin-dependent inflammatory and prothrombogenic phenotype that we have observed in the cerebral microcirculation of {beta}S mice may explain, at least in part, the greater vulnerability of the brain to ischemic strokes in patients with SCD. This appears tenable in view of several published reports that implicate the recruitment of platelets and leukocytes in the brain injury and tissue dysfunction that is associated with strokes (11, 41, 42).

Our observation that leukocytes adhere in the cerebral microcirculation of {beta}S mice is consistent with published reports from other laboratories describing enhanced baseline and H/R- or tumor necrosis factor-{alpha}-stimulated leukocyte adhesion in cremasteric venules of SCD mice (18, 40). Our data show an approximate twofold increase in baseline leukocyte adhesion in cerebral venules of {beta}S mice (Fig. 1) that is not significantly enhanced by 2 h hypoxia followed by 4 h reoxygenation (Fig. 3). Kaul and Hebbel (18) reported a doubling of leukocyte adhesion in cremasteric venules of {beta}S mice. Similarly, Turhan and associates (40) noted that baseline and tumor necrosis factor-{alpha}-stimulated leukocyte rolling and adhesion in postcapillary and collecting venules of the cremaster muscle of sickle cell transgenic mice are nearly twice those observed in WT controls. The quantitatively similar leukocyte adhesion responses of the brain and cremaster circulations to experimental SCD raises the possibility that this inflammatory phenotype is exhibited in a variety of different vascular beds.

Previous intravital microscopic studies of leukocyte adhesion in cremasteric venules of mice with experimental SCD have demonstrated significant attenuation of adhesion following administration of a P-selectin blocking monoclonal antibody (18). These observations, coupled to reports of elevated expression of P-selectin on circulating endothelial cells isolated from patients with SCD (33) and recent data that describe an increased expression of P-selectin in different regional vascular beds of {beta}S mice (44), implicate endothelial cell P-selectin as a key mediator of the leukocyte recruitment associated with experimental SCD. The results of the present study support and significantly extend these observations. We observed that bone marrow transfer from {beta}S mice into P-selectin–/– mice yields a leukocyte adhesion response that is comparable to that observed in WT mice receiving bone marrow from other WT mice but is significantly lower than the adhesion response seen when bone marrow is transferred from {beta}S mice into WT mice. Our findings indicate that P-selectin expressed by cerebral venular endothelium is critical for the recruitment of adherent leukocytes in {beta}S chimeric mice. An important and novel observation in the present study is that endothelial cell-associated P-selectin also mediates platelet recruitment observed in cerebral venules of {beta}S mice. Therefore, our observations suggest that therapeutic application of P-selectin-directed interventions may be useful in blunting both the inflammatory and prothrombogenic responses that are elicited in the cerebral circulation by SCD.

In addition to demonstrating that SCD cerebral venules exhibit enhanced platelet interactions with the vascular wall, our studies also provide novel insight into the relative contributions of endothelial cell versus platelet activation in SCD prothrombogenic responses. Our data show an approximate fourfold increase in baseline platelet adhesion in cerebral venules of {beta}S mice (Fig. 2) that is not significantly enhanced by 2 h hypoxia followed by 4 h reoxygenation (Fig. 4). Moreover, we demonstrate that {beta}S platelets adhere comparably to WT platelets in WT mice, whereas the adhesion of WT platelets is comparable to {beta}S platelets in {beta}S mice (Fig. 2). These observations indicate that {beta}S mice exhibit a prothrombogenic phenotype that largely reflects changes in the adhesivity of the venular wall rather than circulating platelets. This possibility is supported by our findings in the {beta}S chimeric mice that were created to determine whether the elevated platelet adhesion noted in the cerebral microvasculature of {beta}S mice, similar to leukocyte adhesion, is mediated by vascular P-selectin. Complete inhibition of platelet adhesion was noted in chimeric mice wherein the vessel wall (recipient mice) was deficient in P-selectin while circulating platelets (from {beta}S marrow donor) retained the capacity to express P-selectin (Fig. 6). Whereas endothelial cells clearly play a major role in promoting the adhesion of platelets as well as leukocytes in {beta}S chimeric mice, the exact nature of this endothelial cell-dependent response remains unclear. One possible explanation relates to reports describing an oxidative stress in the vasculature of SCD mice (3, 26). This oxidative stress may contribute to a P-selectin involved, proadhesive environment on the endothelial cell surface that facilitates the capture of both platelets and leukocytes, as previously demonstrated in other experimental models (6, 15).


   ACKNOWLEDGMENTS
 
GRANTS

This study was supported by National Heart, Lung, and Blood Institute Grants HL-26441 and P01-HL-55552.


   FOOTNOTES
 

Address for reprint requests and other correspondence: D. Neil Granger, Dept. of Molecular and Cellular Physiology, LSU Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71130-3932 (E-mail: dgrang{at}lsuhsc.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


   REFERENCES
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Andrioli G, Ortolani R, Fontana L, Gaino S, Bellavite P, Lechi C, Minuz P, Manzato F, Tridente G, and Lechi A. Study of platelet adhesion in patients with uncomplicated hypertension. J Hypertens 14: 1215–1221, 1996.[Web of Science][Medline]
  2. Antonucci R, Walker R, Herion J, and Orringer E. Enhancement of sickle erythrocyte adherence to endothelium by autologous platelets. Am J Hematol 34: 44–48, 1990.[Web of Science][Medline]
  3. Aslan M, Ryan TM, Adler B, Townes TM, Parks DA, Thompson JA, Tousson A, Gladwin MT, Patel RP, Tarpey MM, Batinic-Haberle I, White CR, and Freeman BA. Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proc Natl Acad Sci USA 98: 15215–15220, 2001.[Abstract/Free Full Text]
  4. Brittain HA, Eckman JR, Swerlick RA, Howard RJ, and Wick TM. Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential role for platelet activation in sickle cell vaso-occlusion. Blood 81: 2137–2143, 1993.[Abstract/Free Full Text]
  5. Cerwinka WH, Cooper D, Krieglstein CF, Feelisch M, and Granger DN. Nitric oxide modulates endotoxin-induced platelet-endothelial cell adhesion in intestinal venules. Am J Physiol Heart Circ Physiol 282: H1111–H1117, 2002.[Abstract/Free Full Text]
  6. Cerwinka WH, Cooper D, Krieglstein CF, Ross CR, McCord JM, and Granger DN. Superoxide mediates endotoxin-induced platelet-endothelial cell adhesion in intestinal venules. Am J Physiol Heart Circ Physiol 284: H535–H541, 2003.[Abstract/Free Full Text]
  7. Chies JA and Nardi NB. Sickle cell disease: a chronic inflammatory condition. Med Hypotheses 57: 46–50, 2001.[CrossRef][Web of Science][Medline]
  8. Croizat H. Circulating cytokines in sickle cell patients during steady state. Br J Haematol 87: 592–597, 1994.[Web of Science][Medline]
  9. Duits AJ, Pieters RC, Saleh AW, van Rosmalen E, Katerberg H, Berend K, and Rojer RA. Enhanced levels of soluble VCAM-1 in sickle cell patients and their specific increment during vasoocclusive crisis. Clin Immunol Immunopathol 81: 96–98, 1996.[CrossRef][Web of Science][Medline]
  10. Francis RB. Large-vessel occlusion in sickle cell disease: pathogenesis, clinical consequences, and therapeutic implications. Med Hypotheses 35: 88–95, 1991.[CrossRef][Web of Science][Medline]
  11. Galante A, Pietroiusti A, Silvestrini M, Stanzione P, Domenici B, and Bernardi G. Leukocyte and platelet aggregation in patients with ischemic stroke: a case-control study. Eur Neurol 33: 442–445, 1993.[Web of Science][Medline]
  12. Graido-Gonzalez E, Doherty JC, Bergreen EW, Organ G, Telfer M, and McMillen MA. Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis. Blood 92: 2551–2555, 1998.[Abstract/Free Full Text]
  13. Hazama F, Ozaki T, and Amano S. Scanning electron microscopic study of endothelial cells of cerebral arteries from spontaneously hypertensive rats. Stroke 10: 245–252, 1979.[Abstract/Free Full Text]
  14. Hebbel RP and Vercellotti GM. The endothelial biology of sickle cell disease. J Lab Clin Med 129: 288–293, 1997.[CrossRef][Web of Science][Medline]
  15. Horie Y, Wolf R, Anderson DC, and Granger DN. Hepatic leukostasis and hypoxic stress in adhesion molecule-deficient mice after gut ischemia/reperfusion. J Clin Invest 99: 781–788, 1997.[Web of Science][Medline]
  16. Inwald DP, Kirkham FJ, Peters MJ, Lane R, Wade A, Evans JP, and Klein NJ. Platelet and leucocyte activation in childhood sickle cell disease: association with nocturnal hypoxaemia. Br J Haematol 111: 474–481, 2000.[CrossRef][Web of Science][Medline]
  17. Katayama T, Ikeda Y, Handa M, Tamatani T, Sakamoto S, Ito M, Ishimura Y, and Suematsu M. Immunoneutralization of glycoprotein Ibalpha attenuates endotoxin-induced interactions of platelets and leukocytes with rat venular endothelium in vivo. Circ Res 86: 1031–1037, 2000.[Abstract/Free Full Text]
  18. Kaul DK and Hebbel RP. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice [Comment][Erratum J Clin Invest 106:715, 2000]. J Clin Invest 106: 411–420, 2000.[Web of Science][Medline]
  19. Kaul DK, Liu XD, Fabry ME, and Nagel RL. Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse. Am J Physiol Heart Circ Physiol 278: H1799–H1806, 2000.[Abstract/Free Full Text]
  20. Koshy M, Thomas C, and Goodwin J. Vascular lesions in the central nervous system in sickle cell disease (neuropathology). J Assoc Acad Minor Phys 1: 71–78, 1990.[Medline]
  21. Lard LR, Mul FP, de Haas M, Roos D, and Duits AJ. Neutrophil activation in sickle cell disease. J Leukoc Biol 66: 411–415, 1999.[Abstract]
  22. Lominadze D, Joshua IG, and Schuschke DA. In vivo platelet thrombus formation in microvessels of spontaneously hypertensive rats. Am J Hypertens 10: 1140–1146, 1997.[CrossRef][Web of Science][Medline]
  23. Makis AC, Hatzimichael EC, and Bourantas KL. The role of cytokines in sickle cell disease. Ann Hematol 79: 407–413, 2000.[CrossRef][Web of Science][Medline]
  24. Massberg S, Enders G, Leiderer R, Eisenmenger S, Vestweber D, Krombach F, and Messmer K. Platelet-endothelial cell interactions during ischemia/reperfusion: the role of P-selectin. Blood 92: 507–515, 1998.[Abstract/Free Full Text]
  25. Mehta P and Mehta J. Circulating platelet aggregates in sickle cell disease patients with and without vaso-occlusion. Stroke 10: 464–466, 1979.[Abstract/Free Full Text]
  26. Nath KA, Grande JP, Haggard JJ, Croatt AJ, Katusic ZS, Solovey A, and Hebbel RP. Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease. Am J Pathol 158: 893–903, 2001.[Abstract/Free Full Text]
  27. Nishijima K, Kiryu J, Tsujikawa A, Honjo M, Nonaka A, Yamashiro K, Kamizuru H, Ieki Y, Tanihara H, Honda Y, and Ogura Y. Inhibitory effects of antithrombin III on interactions between blood cells and endothelial cells during retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 44: 332–341, 2003.[Abstract/Free Full Text]
  28. Osarogiagbon UR, Choong S, Belcher JD, Vercellotti GM, Paller MS, and Hebbel RP. Reperfusion injury pathophysiology in sickle transgenic mice. Blood 96: 314–320, 2000.[Abstract/Free Full Text]
  29. Paszty C, Brion CM, Manci E, Witkowska HE, Stevens ME, Mohandas N, and Rubin EM. Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science 278: 876–878, 1997.[Abstract/Free Full Text]
  30. Pegelow CH, Macklin EA, Moser FG, Wang WC, Bello JA, Miller ST, Vichinsky EP, DeBaun MR, Guarini L, Zimmerman RA, Younkin DP, Gallagher DM, and Kinney TR. Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood 99: 3014–3018, 2002.[Abstract/Free Full Text]
  31. Reed W, Jagust W, Al-Mateen M, and Vichinsky E. Role of positron emission tomography in determining the extent of CNS ischemia in patients with sickle cell disease. Am J Hematol 60: 268–272, 1999.[CrossRef][Web of Science][Medline]
  32. Solovey A, Gui L, Key NS, and Hebbel RP. Tissue factor expression by endothelial cells in sickle cell anemia. J Clin Invest 101: 1899–1904, 1998.[Web of Science][Medline]
  33. Solovey A, Lin Y, Browne P, Choong S, Wayner E, and Hebbel RP. Circulating activated endothelial cells in sickle cell anemia. N Engl J Med 337: 1584–1590, 1997.[Abstract/Free Full Text]
  34. Sugihara K, Sugihara T, Mohandas N, and Hebbel RP. Thrombospondin mediates adherence of CD36+ sickle reticulocytes to endothelial cells. Blood 80: 2634–2642, 1992.[Abstract/Free Full Text]
  35. Suzuki H, Zweifach BW, Forrest MJ, and Schmid-Schonbein GW. Modification of leukocyte adhesion in spontaneously hypertensive rats by adrenal corticosteroids. J Leukoc Biol 57: 20–26, 1995.[Abstract]
  36. Tailor A and Granger DN. Hypercholesterolemia promotes P-selectin-dependent platelet-endothelial cell adhesion in postcapillary venules. Arterioscler Thromb Vasc Biol 23: 675–680, 2003.[Abstract/Free Full Text]
  37. Tomer A, Harker LA, Kasey S, and Eckman JR. Thrombogenesis in sickle cell disease [Comment]. J Lab Clin Med 137: 398–407, 2001.[CrossRef][Web of Science][Medline]
  38. Tomita Y, Sachs DH, and Sykes M. Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow. Blood 83: 939–948, 1994.[Abstract/Free Full Text]
  39. Tsujikawa A, Kiryu J, Yamashiro K, Nonaka A, Nishijima K, Honda Y, and Ogura Y. Interactions between blood cells and retinal endothelium in endotoxic sepsis. Hypertension 36: 250–258, 2000.[Abstract/Free Full Text]
  40. Turhan A, Weiss LA, Mohandas N, Coller BS, and Frenette PS. Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm. Proc Natl Acad Sci USA 99: 3047–3051, 2002.[Abstract/Free Full Text]
  41. Uchiyama S, Yamazaki M, and Maruyama S. Role of platelet-activating factor in aggregation of leukocytes and platelets in cerebral ischemia. Lipids 26: 1247–1249, 1991.[Web of Science][Medline]
  42. Watson BD, Prado R, Veloso A, Brunschwig JP, and Dietrich WD. Cerebral blood flow restoration and reperfusion injury after ultraviolet laser-facilitated middle cerebral artery recanalization in rat thrombotic stroke. Stroke 33: 428–434, 2002.[Abstract/Free Full Text]
  43. Westwick J, Watson-Williams EJ, Krishnamurthi S, Marks G, Ellis V, Scully MF, White JM, and Kakkar VV. Platelet activation during steady state sickle cell disease. J Med 14: 17–36, 1983.[CrossRef][Web of Science][Medline]
  44. Wood KC, Russell J, Hebbel RP, and Granger DN. Differential expression of E- and P-selectin in the microvasculature of sickle cell transgenic mice. Microcirculation. In press.
  45. Wun T, Paglieroni T, Field CL, Welborn J, Cheung A, Walker NJ, and Tablin F. Platelet-erythrocyte adhesion in sickle cell disease. J Investig Med 47: 121–127, 1999.[Web of Science][Medline]
  46. Wun T, Paglieroni T, Rangaswami A, Franklin PH, Welborn J, Cheung A, and Tablin F. Platelet activation in patients with sickle cell disease. Br J Haematol 100: 741–749, 1998.[CrossRef][Web of Science][Medline]



This article has been cited by other articles:


Home page
 BloodHome page
A. C. Frei, Y. Guo, D. W. Jones, K. A. Pritchard Jr, K. A. Fagan, N. Hogg, and N. J. Wandersee
Vascular dysfunction in a murine model of severe hemolysis
Blood, July 15, 2008; 112(2): 398 - 405.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
W. C. Aird
Phenotypic Heterogeneity of the Endothelium: II. Representative Vascular Beds
Circ. Res., February 2, 2007; 100(2): 174 - 190.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
T. Petnehazy, D. Cooper, K. Y. Stokes, J. Russell, K. C. Wood, and D. N. Granger
Angiotensin II type 1 receptors and the intestinal microvascular dysfunction induced by ischemia and reperfusion
Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1203 - G1210.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
T. Petnehazy, K. Y. Stokes, K. C. Wood, J. Russell, and D. N. Granger
Role of Blood Cell-Associated AT1 Receptors in the Microvascular Responses to Hypercholesterolemia
Arterioscler Thromb Vasc Biol, February 1, 2006; 26(2): 313 - 318.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. H. Embury, N. M. Matsui, S. Ramanujam, T. N. Mayadas, C. T. Noguchi, B. A. Diwan, N. Mohandas, and A. T. W. Cheung
The contribution of endothelial cell P-selectin to the microvascular flow of mouse sickle erythrocytes in vivo
Blood, November 15, 2004; 104(10): 3378 - 3385.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
286/5/H1608    most recent
01056.2003v2
01056.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wood, K. C.
Right arrow Articles by Granger, D. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wood, K. C.
Right arrow Articles by Granger, D. N.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.